PPT-The Influence of Type 2 Diabetes on Cardiovascular Disease

and Glycemic Treatment Options Rocky MountainACP Internal Medicine Conference Banff AB November 22 2012 David CW Lau MD PhD FRCPC Depts of Medicine Biochem amp Molec. Chapter . 10: . Pediatric Practice. PowerPoint Slides. Pediatric disability. “A disability is an environmentally contextualized health-related limitation in a child’s existing or emergent capacity to perform developmentally appropriate activities and participate, as desired, in society.”. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. periodontium. . . Endocrine diseases such as diabetes and hormonal . fluctuations,that. are associated with puberty and pregnancy are well known examples of systemic conditions that . adversally. Objectives. Diabetes overview. Type 1. Gestational diabetes. Type 2. Diabetes: Definition. Increased blood sugar as a result of insulin deficiency or resistance. Type 1- Autoimmune disorder. Type 2- Acquired insulin deficiency or resistance. Deepak L. Bhatt, MD, MPH. Professor . of Medicine, Harvard Medical School. Executive Director of Interventional Cardiovascular Programs. Brigham & Women’s Hospital Heart and Vascular Center. Boston, Massachusetts. 1. Obesity. Management of Common Comorbidities in Diabetes. 2. 3. 4. More Than Two Thirds of US Adults Are Overweight or Obese. 5. *2014 rate of overweight not reported in . Flegal. et al 2016; 2012 rate carried over based on historic stability of overweight prevalence.. Clinical Presentation of Type 2 Diabetes 1 Age ≥45 years Family history of T2D or cardiovascular disease Overweight or obese Sedentary lifestyle Non-Caucasian ancestry Previously identified IGT, IFG, and/or metabolic syndrome results in increased concentrations of glucose in the blood, which in turn damage the blood vessels and nerves.. Diabetes mellitus is a group of metabolic disorders sharing the common feature of . hyperglycemia. 2018 ADA GUIDELINES. Dr. . Sanjana. Bhagwat. Moderator : Dr. S. . Jotkar. Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Backgrounde International Diabetes Federation (IDF) estimates that worldwide, 415 million people have diabetes, 91% of whom have type 2 diabetes mellitus (T2DM) []. People with diabetes comprise 8.8% Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC. Professor and Director. Heart Disease Prevention Program. Division of Cardiology. University of California, Irvine. Editorial Lead, ACC Diabetes and Cardiometabolic Clinical Topic Collection. Farzad. . Hadaegh. , MD, . Professor of Internal Medicine & Endocrinology. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences . GGC MCN meeting 5. th. February 2019. John R Petrie. Professor of Diabetic Medicine. University of Glasgow, UK. Advisory and Consultancy Work:. Novo Nordisk, Sanofi-Aventis, Biocon, Astra Zeneca, . Servier. Dr Shanti Vijayaraghavan, . Consultant . Diabetologist. , . Barts. Health, London. 15 May 2015. Acute or Short-term Complications. 1. Hypoglycaemia: low blood glucose level. 2. Hyperglycaemia:. Diabetic .